Prompt

Can you recommend therapeutic antibody research newsletters for tracking protein-engineered therapies and biologics pipeline examples?

Latest observation

Jul 31, 2026 · OpenAI APIWeb search: off

Yes — here are solid newsletters and update sources for therapeutic antibody research, with emphasis on protein-engineered therapies, biologics, and pipeline examples.

Good newsletters / email alerts

1) Antibody Society

  • Best for: therapeutic antibody trends, approvals, clinical pipeline updates
  • Why useful: curated, antibody-specific, and research-oriented
  • Search for: “Antibody Society newsletter” / “Antibody therapeutics pipeline”

2) BioCentury

  • Best for: biologics industry intelligence, deal flow, clinical pipeline movement
  • Why useful: strong coverage of engineered antibodies, multispecifics, ADCs, and platform companies
  • Note: much of it is premium, but newsletters are very informative

3) Endpoints News

  • Best for: pipeline news, biotech company developments, clinical readouts
  • Why useful: good for tracking who is advancing engineered biologics and antibody programs
  • Search for specific newsletters around biotech/clinical development

4) STAT biotech newsletters

  • Best for: broad biotech and drug development updates
  • Why useful: occasionally covers antibody engineering, immunotherapy, and biologics strategy

5) Fierce Biotech / Fierce Pharma

  • Best for: industry pipeline and company news
  • Why useful: easy-to-scan summaries of biologics, antibody-drug conjugates, and partnership activity
  • They offer multiple free newsletter options

6) GEN (Genetic Engineering & Biotechnology News)

  • Best for: biologics research, platform technologies, translational biotech
  • Why useful: often covers protein engineering, next-gen antibodies, and therapeutic modalities

7) The Antibody Society journal/pipeline alerts

  • If you want a more technical and structured pipeline view, this is especially relevant for:
    • approved antibody therapeutics
    • clinical-stage monoclonals
    • bispecifics and related engineered formats

Useful broader biologics/pipeline newsletters

These are not antibody-only, but they’re good for pipeline examples:

  • Evaluate Vantage / Evaluate Pharma
    Strong for market and pipeline analysis of biologics
  • Scrip
    Good for pharma industry pipeline, partnering, and R&D news
  • Nature Biotechnology newsletters
    Good for protein engineering, platform papers, and translational advances
  • The Translational Scientist / Clinical trial newsletters
    Helpful for linking research to development-stage assets

If you want the most relevant mix

For your use case, I’d start with:

  1. Antibody Society
  2. BioCentury
  3. Endpoints News
  4. GEN
  5. Fierce Biotech

That combination gives you:

  • research depth
  • pipeline visibility
  • business/partnering context
  • engineered biologics coverage

Tip: how to filter for protein-engineered therapies

When scanning newsletters, prioritize terms like:

  • bispecific antibody
  • multispecific
  • Fc engineering
  • half-life extension
  • antibody-drug conjugate (ADC)
  • fusion protein
  • de novo protein
  • affinity maturation
  • conditional activation
  • cytokine engineering
  • protein scaffolds / binders

If you want, I can also make you a ranked list of the best free newsletters only, or a more academic list focused on therapeutic protein engineering papers and preclinical pipeline tracking.

Observation history

Unlock observation history

Create a free Obsurfable account to unlock historical responses, model comparisons, and deeper brand intelligence.

How did Obsurfable measure this prompt?

Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.

Which AI systems does Obsurfable collect answers from?

OpenAI, ChatGPT, Google, Gemini, Google AI Mode, Anthropic, Claude, Perplexity, Grok, DeepSeek, Mistral, Copilot, and Meta AI.